RPAM
AKRO

Rhenman & Partners Asset Management’s Akero Therapeutics AKRO Stock Holding History

Rhenman & Partners Asset Management’s Portfolio AKRO Stock Details AKRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-230,600
Closed -$10.9M – 96
2025
Q3 		$10.9M Buy
230,600
+33,000
+17% +$1.6M 1.21% 33
2025
Q2 		$10.5M Buy
197,600
+105,100
+114% +$4.78M 1.33% 31
2025
Q1 		$3.74M Buy
+92,500
New +$3.92M 0.43% 54

Other funds holding AKRO

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return